Have you ever stopped to think about how a family-owned company can grow so much without losing Brazilian control? Well, that’s exactly what the story of João Adibe and Cimed shows—a journey that demonstrates how strategic vision and execution can transform a business.

João Adibe Marques was born in São Paulo in 1972, but everything really began long before that. His grandfather, João Marques, was a pioneer in the pharmaceutical industry back in the 1950s with Laboratório Prata. Then his father also got involved in the sector, building his own companies. The result? João grew up in a business environment from an early age. At 15, he was already working at the Hornoterápica laboratory, helping his father. He didn’t pursue a traditional academic education—he chose to dive straight into entrepreneurship.

Cimed itself was born in 1977, as a result of a merger of companies in the sector, including Grupo Windson. At first, it was run by João’s father and his sister, Karla Marques Felmanas, who later became vice president. But over time, João took over as president and started making changes.

What stands out is that even with exponential growth, the company remained 100% Brazilian and under family control. That’s very rare in the industry. João Adibe turned Cimed from a regular laboratory into a popular brand focused on generics, vitamins, and supplements for people who need affordable prices. The strategy was aggressive—he threw himself into the generics market with a focus on nationwide reach.

The numbers speak for themselves: the company reached about 90% of pharmacies in Brazil, with more than 600 products in its portfolio and approximately 5,000 employees. In 2018, revenue surpassed R$ 1 billion. Then 2020 came, and things accelerated even more. With the pandemic increasing demand for vitamins and supplements, the segment grew by about 35%. Cimed’s gross revenue reached R$ 2 billion, representing growth of approximately 25% compared with the previous year. This cemented the company among the four largest pharmaceutical companies in Brazil.

What’s interesting is that João Adibe didn’t stop at medicine. He started linking Cimed with innovation on a much more ambitious level. He announced investments of about R$ 300 million over five years in research, including at the Estação Espacial Internacional. The goal? To develop new products and reposition the brand as a biotech company, not just a traditional pharmaceutical one. An ambitious project, but one that clearly reflects a differentiation strategy.

Outside the corporate sphere, João Adibe built a strong presence in sports. Cimed has been investing in sports marketing since the 1990s—sponsoring football teams, boasting a winning history in men’s volleyball, and maintaining its own team in Stock Car. For him, the sports logic of teamwork and discipline applies directly to business.

He is married to Cinthya Adibe, a frequent presence at business events and in social column features. He moved to Florianópolis in search of a better quality of life. On social media, he shares his routine and philosophy with the hashtag #FlyNow. He was also included among the 500 most influential people in Latin America, according to Bloomberg Línea.

João Adibe’s journey and the fortune he accumulated reflect the profile of an entrepreneur who combines a family background with practical execution and keen market insight. As the owner of Cimed, he helped turn the company into a national powerhouse while maintaining Brazilian control in a highly competitive industry. It shows that operational discipline, brand positioning, and strategy can be just as decisive as any technological innovation.